Macy's, Inc.

Based on a comprehensive analysis of Macy's (M), the stock presents a high-risk, turnaround case with significant challenges.

Technical Analysis Macy's stock shows recent underperformance against the market, reflecting short-term weakness. Its position near the midpoint of its 52-week range suggests it is not overextended, but its high historical volatility requires a strong stomach for price swings.

Fundamentals & Valuation The company's fundamentals are concerning, with declining revenue, severely compressed profitability, and operational inefficiencies. While the TTM P/E ratio suggests deep value, the extremely high forward P/E indicates the market expects a sharp decline in future earnings, creating a major valuation contradiction.

Risk Assessment & Investment Thesis The primary risk is company-specific, tied to its ability to navigate a difficult retail environment and improve its operations. The high beta means the stock will be heavily influenced by market sentiment. An investment here is a speculative bet on a successful turnaround, not a value play on a stable business.

Recommendation: HOLD

Macy's is currently not worth buying for most investors. The stock is a speculative turnaround story plagued by weak fundamentals and a bleak earnings outlook. Until there is clear, sustainable evidence of operational improvement and a reversal in profitability trends, the significant downside risk outweighs the potential for a rebound. Investors should await more positive fundamental catalysts before considering a position.

RockFlow Model Forecast: Three Scenarios for 2026

Based on a comprehensive analysis, here is the 12-month outlook for Macy's (M):

12-Month Outlook for Macy's (M):

The 12-month outlook for Macy's remains highly speculative and hinges on the successful execution of its turnaround strategy. Key catalysts that could drive the stock higher include tangible progress on operational initiatives like smaller-format store openings, robust growth in its luxury segment (Bloomingdale's/Bluemercury), and any strategic actions such as asset monetization of its valuable real estate. The primary risks are significant, including persistent market share loss to competitors, failure to stabilize declining revenue and severely compressed profit margins, and a worsening macroeconomic environment that pressures consumer spending. Given the lack of a consensus analyst target and the stock's highly speculative nature, a realistic target range is wide, between $15 and $25, reflecting the binary outcome of either a successful turnaround or continued deterioration.

Wall Street Consensus

Most Wall Street analysts are optimistic about Macy's, Inc.'s 12-month outlook, with consensus target around $19.78, indicating expected upside potential.

Overall, M has investment potential but also faces challenges. Here are key factors to weigh before investing.

Macy's stock has demonstrated volatile but improving performance over the past year, currently positioned near the midpoint of its 52-week range following significant recovery from its lows.

The stock has shown modest declines over the past one and three months, underperforming the broader market by approximately 5% during this period, indicating short-term weakness relative to market benchmarks despite its high beta suggesting elevated volatility expectations.

Currently trading at $19.92, Macy's sits roughly midway between its 52-week high of $24.41 and low of $9.76, suggesting a neutral position that is neither overbought nor oversold based on this metric, though the substantial maximum drawdown of -30% over the past year highlights the stock's historical volatility.

Revenue & Profitability M's Q3 revenue declined slightly to $4.91 billion from $5.00 billion in Q2, while profitability deteriorated significantly with operating income falling from $155 million to just $42 million. The net profit margin compressed to a minimal 0.22% from 1.74% last quarter, indicating severe pressure on bottom-line results despite a stable gross margin of approximately 42%.

Financial Health The company maintains a manageable debt position with a debt ratio of 31% and interest coverage of 1.68x, though cash flow metrics are concerning with negative operating cash flow per share and cash flow to debt ratio. The current ratio of 1.25 suggests adequate short-term liquidity, but the very low quick ratio of 0.18 indicates limited immediate financial flexibility.

Operational Efficiency Operational efficiency appears challenged with return on equity at a minimal 0.25% and asset turnover of 0.29, reflecting poor capital utilization. The inventory turnover of 0.45 and extended days inventory outstanding of 199 days suggest potential inventory management issues, while negative cash flow ratios indicate inefficiencies in converting operations to cash generation.

Based on the available data, M's valuation presents a significant contradiction. The TTM PE ratio of 10.93 appears deeply undervalued, suggesting the stock is inexpensive relative to its historical earnings. However, the extraordinarily high forward PE of 118.58 and negative PEG ratio indicate a severe collapse in expected future earnings, implying the market anticipates a sharp decline in profitability that makes the current price potentially expensive.

A peer comparison is not possible due to the unavailability of industry average data. This absence of context makes it difficult to determine if M's valuation metrics are outliers within its sector or aligned with broader industry trends. The analysis is therefore limited to an absolute assessment of the metrics without the relative benchmarking that a peer comparison would provide.

Macy's exhibits heightened volatility risk compared to the broader market. Its beta of 1.525 indicates the stock is significantly more volatile, meaning it tends to rise more than the market during upswings but fall more sharply during downturns. This volatility is substantiated by a substantial one-year maximum drawdown of -30.17%, highlighting a history of considerable price declines from recent peaks and posing a notable risk for investors with a low tolerance for portfolio fluctuations.

Beyond volatility, the stock's risk profile shows some mitigating factors. The absence of significant short interest suggests the market does not harbor a strong, concentrated bearish sentiment toward the company. However, being a mid-cap retailer, it may still face liquidity risks compared to larger peers, potentially leading to wider bid-ask spreads, especially during periods of market stress. The primary risks remain tied to company-specific execution and the broader challenges within the competitive retail sector.